181 related articles for article (PubMed ID: 36707207)
1. Current and emerging biomarkers in ovarian cancer diagnosis; CA125 and beyond.
Sharma T; Nisar S; Masoodi T; Macha MA; Uddin S; Akil AA; Pandita TK; Singh M; Bhat AA
Adv Protein Chem Struct Biol; 2023; 133():85-114. PubMed ID: 36707207
[TBL] [Abstract][Full Text] [Related]
2. A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
Russell MR; Graham C; D'Amato A; Gentry-Maharaj A; Ryan A; Kalsi JK; Ainley C; Whetton AD; Menon U; Jacobs I; Graham RLJ
Br J Cancer; 2017 Aug; 117(5):666-674. PubMed ID: 28664912
[TBL] [Abstract][Full Text] [Related]
3. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract][Full Text] [Related]
4. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for Early Diagnosis of Ovarian Carcinoma.
Manasa G; Mascarenhas RJ; Shetti NP; Malode SJ; Aminabhavi TM
ACS Biomater Sci Eng; 2022 Jul; 8(7):2726-2746. PubMed ID: 35762531
[TBL] [Abstract][Full Text] [Related]
6. Molecular Biomarkers for the Early Detection of Ovarian Cancer.
Zhang R; Siu MKY; Ngan HYS; Chan KKL
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233339
[TBL] [Abstract][Full Text] [Related]
7. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.
El Bairi K; Kandhro AH; Gouri A; Mahfoud W; Louanjli N; Saadani B; Afqir S; Amrani M
Cell Oncol (Dordr); 2017 Apr; 40(2):105-118. PubMed ID: 27981507
[TBL] [Abstract][Full Text] [Related]
8. Approaches to the detection of ovarian cancer.
Høgdall E
Scand J Clin Lab Invest Suppl; 2016; 245():S49-53. PubMed ID: 27435369
[TBL] [Abstract][Full Text] [Related]
9. Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges.
Wanyama FM; Blanchard V
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33916250
[TBL] [Abstract][Full Text] [Related]
10. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
11. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract][Full Text] [Related]
12. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Zhang M; Cheng S; Jin Y; Zhao Y; Wang Y
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188503. PubMed ID: 33421585
[TBL] [Abstract][Full Text] [Related]
13. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
14. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
Bonifácio VDB
Adv Exp Med Biol; 2020; 1219():355-363. PubMed ID: 32130708
[TBL] [Abstract][Full Text] [Related]
16. Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.
Tcherkassova J; Abramovich C; Moro R; Chen C; Schmit R; Gerber A; Moro R
Tumour Biol; 2011 Aug; 32(4):831-8. PubMed ID: 21625941
[TBL] [Abstract][Full Text] [Related]
17. Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer.
Gu Z; He Y; Zhang Y; Chen M; Song K; Huang Y; Li Q; Di W
J Transl Med; 2018 May; 16(1):114. PubMed ID: 29716620
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum and tissue HE4 expression in ovarian cancer: a systematic review with meta-analysis of 90 studies.
Cao H; You D; Lan Z; Ye H; Hou M; Xi M
Expert Rev Mol Diagn; 2018 Apr; 18(4):371-383. PubMed ID: 29569984
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer detection by DNA methylation in cervical scrapings.
Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
